303 related articles for article (PubMed ID: 32132976)
1. A Novel Risk Stratification System for Thyroid Nodules With Indeterminate Cytology-A Pilot Cohort Study.
Gomes-Lima CJ; Auh S; Thakur S; Zemskova M; Cochran C; Merkel R; Filie AC; Raffeld M; Patel SB; Xi L; Wartofsky L; Burman KD; Klubo-Gwiezdzinska J
Front Endocrinol (Lausanne); 2020; 11():53. PubMed ID: 32132976
[No Abstract] [Full Text] [Related]
2. Do Ultrasound Patterns and Clinical Parameters Inform the Probability of Thyroid Cancer Predicted by Molecular Testing in Nodules with Indeterminate Cytology?
Figge JJ; Gooding WE; Steward DL; Yip L; Sippel RS; Yang SP; Scheri RP; Sipos JA; Mandel SJ; Mayson SE; Burman KD; Folek JM; Haugen BR; Sosa JA; Parameswaran R; Tan WB; Nikiforov YE; Carty SE
Thyroid; 2021 Nov; 31(11):1673-1682. PubMed ID: 34340592
[No Abstract] [Full Text] [Related]
3. ACR TI-RADS and ATA US scores are helpful for the management of thyroid nodules with indeterminate cytology.
Barbosa TLM; Junior COM; Graf H; Cavalvanti T; Trippia MA; da Silveira Ugino RT; de Oliveira GL; Granella VH; de Carvalho GA
BMC Endocr Disord; 2019 Oct; 19(1):112. PubMed ID: 31664992
[TBL] [Abstract][Full Text] [Related]
4. (99m)Tc-Methoxy-Isobutyl-Isonitrile Scintigraphy Is a Useful Tool for Assessing the Risk of Malignancy in Thyroid Nodules with Indeterminate Fine-Needle Cytology.
Campennì A; Giovanella L; Siracusa M; Alibrandi A; Pignata SA; Giovinazzo S; Trimarchi F; Ruggeri RM; Baldari S
Thyroid; 2016 Aug; 26(8):1101-9. PubMed ID: 27266385
[TBL] [Abstract][Full Text] [Related]
5. Combination of ultrasound and molecular testing in malignancy risk estimate of Bethesda category IV thyroid nodules: results from a single-institution prospective study.
Marina M; Zatelli MC; Goldoni M; Del Rio P; Corcione L; Martorana D; Percesepe A; Bonatti F; Mozzoni P; Crociara A; Ceresini G
J Endocrinol Invest; 2021 Dec; 44(12):2635-2643. PubMed ID: 33860907
[TBL] [Abstract][Full Text] [Related]
6. Cytology-Ultrasonography Risk-Stratification Scoring System Based on Fine-Needle Aspiration Cytology and the Korean-Thyroid Imaging Reporting and Data System.
Hong MJ; Na DG; Baek JH; Sung JY; Kim JH
Thyroid; 2017 Jul; 27(7):953-959. PubMed ID: 28463597
[TBL] [Abstract][Full Text] [Related]
7. Targeted Next Generation Sequencing with ThyroSeq v2.1 for Indeterminate Thyroid Nodules in Clinical Practice.
Witt RL
Del Med J; 2016 Dec; 88(12):366-372. PubMed ID: 29461717
[TBL] [Abstract][Full Text] [Related]
8. Impact of ultrasonographic features, cytomorphology and mutational testing on malignant and indeterminate thyroid nodules on diagnostic accuracy of fine needle cytology samples: A prospective analysis of 141 patients.
Fulciniti F; Cipolletta Campanile A; Malzone MG; Chiofalo MG; Capiluongo A; Monaco M; Di Maio N; Sandomenico F; Botti G; Chiappetta G; Vuttariello E; Pezzullo L
Clin Endocrinol (Oxf); 2019 Dec; 91(6):851-859. PubMed ID: 31483883
[TBL] [Abstract][Full Text] [Related]
9. The diagnostic accuracy of ultrasound-guided fine-needle aspiration biopsy and the sonographic differences between benign and malignant thyroid nodules 3 cm or larger.
Yoon JH; Kwak JY; Moon HJ; Kim MJ; Kim EK
Thyroid; 2011 Sep; 21(9):993-1000. PubMed ID: 21834673
[TBL] [Abstract][Full Text] [Related]
10. The Added Value of Operator's Judgement in Thyroid Nodule Ultrasound Classification Arising From Histologically Based Comparison of Different Risk Stratification Systems.
Madeo B; Brigante G; Ansaloni A; Taliani E; Kaleci S; Monzani ML; Simoni M; Rochira V
Front Endocrinol (Lausanne); 2020; 11():434. PubMed ID: 32733383
[No Abstract] [Full Text] [Related]
11. Validation of American Thyroid Association Ultrasound Risk Assessment of Thyroid Nodules Selected for Ultrasound Fine-Needle Aspiration.
Tang AL; Falciglia M; Yang H; Mark JR; Steward DL
Thyroid; 2017 Aug; 27(8):1077-1082. PubMed ID: 28657511
[TBL] [Abstract][Full Text] [Related]
12. American Thyroid Association Sonographic Risk and Afirma Gene Expression Classifier Alone and in Combination for the Diagnosis of Thyroid Nodules with Bethesda Category III Cytology.
Arosemena M; Thekkumkattil A; Valderrama ML; Kuker R; Castillo RP; Sidani C; Gonzalez ML; Casula S; Kargi AY
Thyroid; 2020 Nov; 30(11):1613-1619. PubMed ID: 32364010
[No Abstract] [Full Text] [Related]
13. An innovative synthetic support for immunocytochemical assessment of cytologically indeterminate (Bethesda III) thyroid nodules.
Taccogna S; Papini E; Novizio R; D'Angelo M; Turrini L; Persichetti A; Pontecorvi A; Guglielmi R
Front Endocrinol (Lausanne); 2022; 13():1078019. PubMed ID: 36531453
[TBL] [Abstract][Full Text] [Related]
14. Combining the American Thyroid Association's Ultrasound Classification with Cytological Subcategorization Improves the Assessment of Malignancy Risk in Indeterminate Thyroid Nodules.
Larcher de Almeida AM; Delfim RLC; Vidal APA; Chaves MCDCM; Santiago ACL; Gianotti MF; Gonçalves MDDC; Vaisman M; de Carvalho DP; Teixeira PFDS
Thyroid; 2021 Jun; 31(6):922-932. PubMed ID: 33143569
[No Abstract] [Full Text] [Related]
15. Real-world Comparison of Afirma GEC and GSC for the Assessment of Cytologically Indeterminate Thyroid Nodules.
San Martin VT; Lawrence L; Bena J; Madhun NZ; Berber E; Elsheikh TM; Nasr CE
J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 31665322
[TBL] [Abstract][Full Text] [Related]
16. Suggesting the cytologic diagnosis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): A retrospective analysis of atypical and suspicious nodules.
Strickland KC; Howitt BE; Barletta JA; Cibas ES; Krane JF
Cancer Cytopathol; 2018 Feb; 126(2):86-93. PubMed ID: 28914983
[TBL] [Abstract][Full Text] [Related]
17. Value of ultrasound and cytological classification system to predict the malignancy of thyroid nodules with indeterminate cytology.
Maia FF; Matos PS; Pavin EJ; Vassallo J; Zantut-Wittmann DE
Endocr Pathol; 2011 Jun; 22(2):66-73. PubMed ID: 21547508
[TBL] [Abstract][Full Text] [Related]
18. Performance of multigene testing in cytologically indeterminate thyroid nodules and molecular risk stratification.
Zhou Y; Wu X; Zhang Y; Li Z; Ge X; Chen H; Mao Y; Ding W
PeerJ; 2023; 11():e16054. PubMed ID: 37744220
[TBL] [Abstract][Full Text] [Related]
19. Risk Stratification of Thyroid Nodules With Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance (AUS/FLUS) Cytology Using Ultrasonography Patterns Defined by the 2015 ATA Guidelines.
Lee JH; Han K; Kim EK; Moon HJ; Yoon JH; Park VY; Kwak JY
Ann Otol Rhinol Laryngol; 2017 Sep; 126(9):625-633. PubMed ID: 28719972
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of cancer and the benign call rate of afirma gene classifier in
Endo M; Sipos JA; Ringel MD; Porter K; Nagaraja HN; Phay JE; Shirley LA; Long C; Wright CL; Roll K; Nabhan FA
Cancer Med; 2021 Feb; 10(3):1084-1090. PubMed ID: 33449450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]